Literature DB >> 22588352

α-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission.

Darlene A Mitrano1, Jason P Schroeder, Yoland Smith, James J Cortright, Nancy Bubula, Paul Vezina, David Weinshenker.   

Abstract

Brainstem noradrenergic neurons innervate the mesocorticolimbic reward pathway both directly and indirectly, with norepinephrine facilitating dopamine (DA) neurotransmission via α1-adrenergic receptors (α1ARs). Although α1AR signaling in the prefrontal cortex (PFC) promotes mesolimbic transmission and drug-induced behaviors, the potential contribution of α1ARs in other parts of the pathway, such as the ventral tegmental area (VTA) and nucleus accumbens (NAc), has not been investigated before. We found that local blockade of α1ARs in the medial NAc shell, but not the VTA, attenuates cocaine- and morphine-induced locomotion. To determine the neuronal substrates that could mediate these effects, we analyzed the cellular, subcellular, and subsynaptic localization of α1ARs and characterized the chemical phenotypes of α1AR-containing elements within the mesocorticolimbic system using single and double immunocytochemical methods at the electron microscopic (EM) level. We found that α1ARs are found mainly extra-synaptically in axons and axon terminals in the NAc and are enriched in glutamatergic and dopaminergic elements. α1ARs are also abundant in glutamatergic terminals in the PFC, and in GABA-positive terminals in the VTA. In line with these observations, microdialysis experiments revealed that local blockade of α1ARs attenuated the increase in extracellular DA in the medial NAc shell following administration of cocaine. These data indicate that local α1ARs control DA transmission in the medial NAc shell and behavioral responses to drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588352      PMCID: PMC3398716          DOI: 10.1038/npp.2012.68

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  62 in total

1.  Role of CNS alpha1-adrenoceptor activity in central fos responses to novelty.

Authors:  Eric A Stone; Lin Yan; Mohammed R Ahsan; Michael L Lehmann; Joseph Yeretsian; David Quartermain
Journal:  Synapse       Date:  2006-04       Impact factor: 2.562

2.  Identification of the differentiation-associated Na+/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses.

Authors:  Helene Varoqui; Martin K H Schäfer; Heming Zhu; Eberhard Weihe; Jeffrey D Erickson
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release.

Authors:  Agnès Auclair; Susanna Cotecchia; Jacques Glowinski; Jean-Pol Tassin
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

4.  Cortical alpha 1-adrenergic regulation of acute and sensitized morphine locomotor effects.

Authors:  C Drouin; G Blanc; F Trovero; J Glowinski; J P Tassin
Journal:  Neuroreport       Date:  2001-11-16       Impact factor: 1.837

5.  Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons.

Authors:  C A Paladini; C D Fiorillo; H Morikawa; J T Williams
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

6.  Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.

Authors:  David Weinshenker; Nicole S Miller; Katherine Blizinsky; Marc L Laughlin; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

7.  The expression of vesicular glutamate transporters defines two classes of excitatory synapse.

Authors:  R T Fremeau; M D Troyer; I Pahner; G O Nygaard; C H Tran; R J Reimer; E E Bellocchio; D Fortin; J Storm-Mathisen; R H Edwards
Journal:  Neuron       Date:  2001-08-02       Impact factor: 17.173

8.  Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.

Authors:  Candice Drouin; Laurent Darracq; Fabrice Trovero; Gérard Blanc; Jacques Glowinski; Susanna Cotecchia; Jean-Pol Tassin
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

9.  Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.

Authors:  Paul Vezina; Daniel S Lorrain; Gretchen M Arnold; Jennifer D Austin; Nobuyoshi Suto
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

10.  Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons.

Authors:  Stephanie Dallvechia-Adams; Michael J Kuhar; Yoland Smith
Journal:  J Comp Neurol       Date:  2002-07-08       Impact factor: 3.215

View more
  39 in total

Review 1.  Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.

Authors:  Neal R Swerdlow
Journal:  Neurosci Biobehav Rev       Date:  2012-09-24       Impact factor: 8.989

2.  The Roles of Dopamine and α1-Adrenergic Receptors in Cocaine Preferences in Female and Male Rats.

Authors:  Adam N Perry; Christel Westenbroek; Lakshmikripa Jagannathan; Jill B Becker
Journal:  Neuropsychopharmacology       Date:  2015-04-22       Impact factor: 7.853

3.  Acute tramadol enhances brain activity associated with reward anticipation in the nucleus accumbens.

Authors:  Yuki Asari; Yumiko Ikeda; Amane Tateno; Yoshiro Okubo; Takehiko Iijima; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2018-06-27       Impact factor: 4.530

4.  Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons.

Authors:  Maria C Velásquez-Martínez; Rafael Vázquez-Torres; Legier V Rojas; Priscila Sanabria; Carlos A Jiménez-Rivera
Journal:  Neuropharmacology       Date:  2014-09-28       Impact factor: 5.250

5.  Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex.

Authors:  Dibyadeep Datta; Sheng-Tao Yang; Veronica C Galvin; John Solder; Fei Luo; Yury M Morozov; Jon Arellano; Alvaro Duque; Pasko Rakic; Amy F T Arnsten; Min Wang
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

6.  The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior.

Authors:  Jason P Schroeder; S Alisha Epps; Taylor W Grice; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2013-01-03       Impact factor: 7.853

Review 7.  Working mechanism underlying the reduction of the behavioral and accumbal dopamine response to cocaine by α-1-adrenoceptor antagonists.

Authors:  Michel M M Verheij; Tadashi Saigusa; Noriaki Koshikawa; Alexander R Cools
Journal:  Neuropsychopharmacology       Date:  2013-02       Impact factor: 7.853

8.  A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.

Authors:  Tracy L Simpson; Carol A Malte; Bergetta Dietel; Dana Tell; Ian Pocock; Robert Lyons; Dana Varon; Murray Raskind; Andrew J Saxon
Journal:  Alcohol Clin Exp Res       Date:  2015-04-01       Impact factor: 3.455

9.  Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys.

Authors:  Debra A Cooper; Heather L Kimmel; Daniel F Manvich; Karl T Schmidt; David Weinshenker; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

10.  Reciprocal Catecholamine Changes during Opiate Exposure and Withdrawal.

Authors:  Megan E Fox; Nathan T Rodeberg; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.